A breakthrough in the management of AMD
2RT is a minimally invasive, nano-pulse, ophthalmic laser therapy which has demonstrated efficacy the treatment of intermediate age-related macular degeneration (iAMD).
2RT stimulates a natural immune response of the retina, which restores natural metabolite flow and rejuvenates the retinal pigment epithelium. The treatment is safe, with no damage to the overlying neurosensory retina, photoreceptors, or Bruch’s membrane. Importantly, 2RT offers the potential to intervene earlier in the disease process and thereby eliminate, or delay the risk of, vision-threatening complications associated with AMD.